SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-24-001221
Filing Date
2024-08-13
Accepted
2024-08-13 08:06:20
Documents
48
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q artl_10q.htm   iXBRL 10-Q 946784
2 CERTIFICATION artl_ex311.htm EX-31.1 11224
3 CERTIFICATION artl_ex321.htm EX-32.1 3854
  Complete submission text file 0001640334-24-001221.txt   3722814

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA artl-20240630.xsd EX-101.SCH 32115
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE artl-20240630_lab.xml EX-101.LAB 211753
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE artl-20240630_cal.xml EX-101.CAL 33292
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE artl-20240630_pre.xml EX-101.PRE 177423
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE artl-20240630_def.xml EX-101.DEF 99166
51 EXTRACTED XBRL INSTANCE DOCUMENT artl_10q_htm.xml XML 487915
Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

IRS No.: 331220924 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38951 | Film No.: 241198865
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)